Keeping It Sterile: CAPA to the Rescue10/20/2026 A sterile barrier breach is more than a packaging defect. It can put patient safety, product quality, regulatory compliance, and business continuity at risk. In this Square-1 Engineering Lunch & Learn, Lon Goldbaum shared practical strategies for investigating sterile packaging failures, identifying root causes, and building more effective Corrective and Preventive Action (CAPA) processes. For medical device manufacturers, sterile packaging integrity is essential to delivering safe, effective products. When a sterile barrier system fails, teams must determine what happened, contain the issue, assess the risk, and implement a solution that prevents recurrence. But resolving a packaging failure is not always straightforward. The visible defect may be only a symptom of a deeper process issue, and the root cause may be hiding in an unexpected place. In Keeping It Sterile: CAPA to the Rescue, Lon Goldbaum, founder and principal of Goldbaum Strategic Life Science Solutions, draws on more than 25 years of experience in medical device packaging and quality management to explain how teams can approach these challenges systematically. Why sterile barrier breaches matter Sterile barrier systems (SBS) protect sterile medical devices from contamination until the point of use. Depending on the device and packaging configuration, these systems may include pouches, trays, lids, and other validated packaging components. A breach—even a small puncture, cut, or compromised seal—can jeopardize the integrity of the sterile barrier. The consequences extend beyond the packaging itself. Patient safety: A compromised sterile barrier can undermine the assurance of sterility and potentially expose patients to harm. Patient risk should therefore be a primary consideration when assessing a packaging defect. Business continuity: Containment, quarantine, additional inspections, rework, scrap, and manufacturing interruptions can consume significant time and resources. When the issue affects multiple product configurations, the impact can grow quickly. Quality system effectiveness: A defect that escapes detection may indicate gaps in inspection, manufacturing controls, supplier qualification, or process validation. Understanding how the issue occurred is essential to strengthening the quality system. Regulatory compliance: Inadequate investigations, ineffective CAPAs, or unresolved quality system deficiencies can create challenges during audits and regulatory inspections. These risks reinforce an important principle: resolving the immediate defect is only part of the job. Manufacturers must also understand why it occurred and determine whether similar failures could affect other products. CAPA: Fixing the problem versus preventing recurrence Corrective and Preventive Action is a structured approach to investigating quality issues, eliminating their causes, and reducing the likelihood of recurrence. Lon distinguishes between three concepts that are often confused:
The distinction matters because a correction alone may leave the underlying problem untouched. Replacing a damaged pouch resolves that individual defect, but it does not explain why the pouch was damaged in the first place. As Lon emphasizes during the session, fixing the defect solves today's problem; an effective CAPA helps prevent tomorrow's problems. CAPA should also be risk-based. Issues with potential patient safety implications warrant particular urgency, and teams should follow their organization's quality procedures to determine when a CAPA is required. A structured approach to CAPA: The DMAIC methodology A strong CAPA investigation needs a repeatable framework. Lon describes three overarching phases—investigation, improvement, and control—that align with the DMAIC methodology: Define, Measure, Analyze, Improve, and Control. 1. Investigation: Define and measure the problem Before jumping to a solution, the team needs a clear understanding of the issue. Start with a concise problem statement that identifies the affected object and the observed defect. For example: The inner sterile barrier pouches for specified catheter configurations exhibit punctures near the distal end. This gives the team a defined problem to investigate without prematurely assuming a cause. The investigation should also establish the scope of the issue. Consider:
Teams should gather relevant evidence, including inspection records, customer complaints, supplier qualification data, packaging validation results, and manufacturing documentation. Containment decisions and the rationale behind them should also be documented. 2. Improvement: Analyze the root cause and implement the fix One of the most common mistakes in CAPA investigations is moving too quickly from identifying a defect to selecting a solution. The visible failure does not necessarily reveal its cause. A puncture in a sterile pouch, for example, could be related to the packaging material, sealing equipment, handling methods, operator training, environmental conditions, or interactions between the device and its packaging. Lon recommends using structured root cause analysis rather than relying exclusively on the 5 Whys technique. An Ishikawa, or fishbone, diagram helps teams organize potential causes across categories such as materials, machines, methods, manpower, measurement, and environment. The 5 Whys can then help explore specific causal pathways. Combining these tools encourages a broader investigation before the team commits to a root cause. Feasibility testing is another critical step. Rather than immediately implementing a proposed fix, teams can recreate the failure under controlled conditions and evaluate whether the suspected cause actually produces the defect. This approach helps validate root cause hypotheses, compare potential solutions, and build confidence before formal verification and validation activities. 3. Control: Verify effectiveness and prevent recurrence Implementing a corrective action does not automatically mean the problem is solved. The control phase establishes whether the changes achieved their intended result. Depending on the issue, this may involve monitoring consecutive production work orders, reviewing inspection results, or tracking customer complaints over a defined period. The verification-of-effectiveness (VOE) plan should establish measurable acceptance criteria before the team evaluates the results. For sterile packaging, this could mean demonstrating that the identified breach no longer occurs under the specified manufacturing conditions and that the corrective action remains effective over time. Changes may also require updates to procedures, operator training, risk management documentation, packaging validation, supplier qualification, or regulatory submissions, as applicable. A CAPA should be closed based on documented evidence that its required actions are complete and its effectiveness criteria have been met—not simply because the immediate defect has disappeared. Case study: Finding the cause of recurring sterile pouch punctures During the Lunch & Learn, Lon shared a historical case involving an implantable medical device packaged in a double sterile barrier system. The team had identified sterile barrier breaches affecting the inner pouch, but the cause was unclear. Multiple potential root causes were under consideration, and the issue had the potential to affect several product configurations that shared packaging components. The investigation required containment, inspections, cross-functional collaboration, and a closer look at how the product moved through manufacturing. Looking beyond the obvious Rather than limiting the investigation to packaging materials or transportation conditions, Lon went to the manufacturing floor to observe the process directly. That hands-on investigation revealed several important details:
The team then used feasibility testing to evaluate a simpler folding method. Lon reported testing approximately 200 units without observing punctures under the tested conditions. That result supported the proposed solution and helped the team move forward with further corrective action activities. From root cause to resolution The investigation illustrates why a comprehensive CAPA involves more than identifying a single process adjustment. The proposed changes needed to be supported by appropriate verification and validation activities, manufacturing process qualification where applicable, updated procedures, operator retraining, risk documentation, and relevant regulatory assessments. The team also needed a defined plan to verify that the issue did not recur after the changes were implemented. The central lesson is that a seemingly complex packaging failure can sometimes be traced to a relatively simple process interaction—but identifying that interaction requires evidence, structured investigation, and an understanding of how the product is actually manufactured. Building more effective CAPA investigations For medical device teams managing sterile packaging issues, Lon's experience highlights several practical takeaways. Bring the right subject matter experts into the investigation. Packaging, quality, manufacturing, regulatory, and other relevant specialists can contribute different perspectives. Involving the appropriate experts early can prevent teams from spending time investigating unlikely causes. Go to the source. Reviewing records is essential, but observing the process where the defect occurs can reveal details that documentation alone may not capture. Define the problem before solving it. A focused problem statement provides the foundation for the investigation, root cause analysis, and effectiveness criteria. Investigate shared risks. A defect affecting one product may also affect other devices that use the same packaging components, equipment, or manufacturing methods. Test assumptions before committing to a fix. Feasibility testing can help determine whether a suspected cause is credible and whether a proposed solution addresses it. Plan for effectiveness from the beginning. Define what success looks like, how it will be measured, and what evidence is needed to demonstrate that the issue has been resolved. Turning packaging challenges into lasting improvements Effective CAPA is an essential part of maintaining medical device quality and protecting patients. It gives teams a structured way to investigate failures, make evidence-based decisions, and strengthen the processes that support product safety and reliability. As Lon's case study demonstrates, the most effective solutions often come from combining sound quality methodology with practical engineering knowledge and direct observation of manufacturing processes. For organizations facing recurring packaging defects, unclear root causes, or complex remediation efforts, that combination can make the difference between correcting an isolated problem and achieving lasting process improvement. Looking for more support?
If you have questions about this topic or want to explore how our team can help with your MedTech project, contact us here. Want to see what we do? Visit our Services page or contact us directly to talk through your project and see if we’re the right fit.
0 Comments
Leave a Reply. |
About the AuthorTravis Smith is the founder and managing director of Square-1 Engineering, a medical device consulting firm, providing end to end engineering and compliance services. He successfully served the life sciences marketplace in SoCal for over 15 years and has been recognized as a ‘40 Under 40’ honoree by the Greater Irvine Chamber of Commerce as a top leader in Orange County, CA. Archives
November 2026
October 2026
September 2026
August 2026
July 2026
June 2026
April 2026
March 2026
February 2026
January 2026
December 2025
October 2025
September 2025
August 2025
July 2025
June 2025
May 2025
April 2025
January 2025
October 2024
September 2024
August 2024
July 2024
May 2024
April 2024
March 2024
February 2024
January 2024
December 2023
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
November 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
November 2021
October 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
July 2020
June 2020
May 2020
April 2020
March 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
March 2018
February 2018
January 2018
June 2017
May 2017
April 2017
February 2017
December 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
September 2015
|
RSS Feed